Sequence information
Variant position: 337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 419 The length of the canonical sequence.
Location on the sequence:
SNFKYMYWTMLQQLTHHSVN
G CNLRPGDLLASGTISGPEPE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SNFKYMYWTMLQQLTHHSVNG CNLRPGDLLASGTISGPEPE
Mouse SNFKHMYWTMLQQLTHHSVNG CNLRPGDLLASGTISGSDPE
Rat SNFKHMYWTILQQLTHHSVNG CNLRPGDLLASGTISGSDPE
Bovine SNFKYMYWTMLQQLTHHSVNG CNLQPGDLLASGTISGPEPE
Caenorhabditis elegans TNFKHLYWTLKQQLAHHTVNG CNLRAGDLLGSGTVSGPEEG
Slime mold SNLKYMYWTLTQQLAHHTVNG CNMNAGDLLGTGTISGPTED
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 419
Fumarylacetoacetase
Binding site
350 – 350
Literature citations
Two novel mutations involved in hereditary tyrosinemia type I.
St Louis M.; Poudrier J.; Phaneuf D.; Leclerc B.; Laframboise R.; Tanguay R.M.;
Hum. Mol. Genet. 4:319-320(1995)
Cited for: VARIANTS TYRSN1 SER-337 AND GLY-381;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.